Qube Research & Technologies (QRT)’s Immunocore IMCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,015	Closed	-$679K	–	3668
2024 Q4	$679K	Sell	23,015 -168,526	-88%	-$5.33M	﹤0.01%	2341
2024 Q3	$5.96M	Sell	191,541 -60,278	-24%	-$2.19M	0.01%	1301
2024 Q2	$8.53M	Buy	251,819 +159,822	+174%	+$8.15M	0.01%	990
2024 Q1	$5.98M	Buy	91,997 +33,653	+58%	+$2.31M	0.01%	1133
2023 Q4	$3.99M	Sell	58,344 -66,855	-53%	-$3.47M	0.01%	1168
2023 Q3	$6.5M	Buy	125,199 +63,232	+102%	+$3.74M	0.02%	820
2023 Q2	$3.72M	Sell	61,967 -91,842	-60%	-$5.24M	0.01%	797
2023 Q1	$7.6M	Sell	153,809 -11,656	-7%	-$655K	0.03%	550
2022 Q4	$9.44M	Buy	+165,465	New	+$9.31M	0.05%	507

Other funds holding IMCR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMCR Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Immunocore (IMCR) in Q1 2025, closing a stake of 23,015 shares — an estimated $679K sold.

Qube Research & Technologies (QRT) first reported a position in IMCR in Q4 2022 and held it in 9 quarters. The position peaked at $9.44M in Q4 2022. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

Qube Research & Technologies (QRT) reported no remaining Immunocore position as of Q1 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 23,015 Immunocore shares in Q1 2025, an estimated $679K.
Qube Research & Technologies (QRT) first reported a position in Immunocore in Q4 2022 and held it in 9 quarters.
Qube Research & Technologies (QRT)'s Immunocore position peaked at $9.44M in Q4 2022.
116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.